Indefinite Delivery Contract 36C25625D0004

The key products and services being delivered under this federal contract IDV award are specialized pharmacy services and hazardous compounding for chemotherapy and other intravenous medications to support the Department of Veterans Affairs (VA) healthcare system. The prime contractor, Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy), a subsidiary of UnitedHealth Group Incorporated, has been awarded a single-award Indefinite Delivery Contract (IDC) worth $6.75 million by the VA Veterans Integrated Service Network (VISN) 16 to provide hazardous compounding services for the Biloxi, MS and Pensacola, FL VA medical facilities.

The contract requires Optum Pharmacy 801, Inc. to compound customized chemotherapy agents, hazardous sterile preparations, and other patient-specific intravenous medications to support the VA's oncology and infusion treatment programs. Optum Pharmacy 801, Inc. will be responsible for providing all necessary supplies, transporting the compounded orders to the VA locations, and meeting strict quality and compliance standards. This IDC has a base period from October 1, 2024 through September 30, 2025 with four one-year option periods. The contract is not associated with any set-aside designation, and Optum Pharmacy 801, Inc. will likely perform the work at its facilities in Phoenix, Arizona while partnering with the VA medical centers.